Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SANOFI-AVENTIS US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

INSULIN LISPRO

Brand Name : ADMELOG

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

Approval Date :

Application Number : 209196

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner

02

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

INSULIN LISPRO

Brand Name : ADMELOG SOLOSTAR

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Approval Date :

Application Number : 209196

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner

03

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

INSULIN LISPRO

Brand Name : ADMELOG

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Approval Date :

Application Number : 209196

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner